Article Details

Lyme Disease Vaccine Candidate Secures Pfizer Investment

Retrieved on: 2022-06-20 13:46:38

Tags for this article:

Click the tags to see associated articles and topics

Lyme Disease Vaccine Candidate Secures Pfizer Investment. View article details on hiswai:

Excerpt

France-based Valneva SE and Pfizer Inc. today announced that they have entered into new agreements for the Lyme disease vaccine candidate VLA15.

Article found on: www.precisionvaccinations.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up